In this article, we will discuss the 10 best medical stocks under $10. To skip our detailed analysis of the healthcare sector, go directly to the 5 Best Medical Stocks Under $10. According to the Centers for Medicare and Medicaid Services, U.S spending on national healthcare touched $4.1 trillion in 2020, which amounts to an […]
Amicus Therapeutics (FOLD) posts a narrower-than-expected loss for the second quarter. FOLD's sole marketed drug Galafold's solid sales drive the top line.
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 8.70% and 5.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?